
Willis Ray Wolfe Jr.
Examiner (ID: 3961)
| Most Active Art Unit | 3402 |
| Art Unit(s) | 3405, 3402, 3747, 3727, 2102 |
| Total Applications | 3167 |
| Issued Applications | 2975 |
| Pending Applications | 60 |
| Abandoned Applications | 133 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18071422
[patent_doc_number] => 11530245
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-12-20
[patent_title] => Split intein mediated polymerization and production of mussel foot adhesive protein materials
[patent_app_type] => utility
[patent_app_number] => 16/554171
[patent_app_country] => US
[patent_app_date] => 2019-08-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 33
[patent_figures_cnt] => 41
[patent_no_of_words] => 7869
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 122
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16554171
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/554171 | Split intein mediated polymerization and production of mussel foot adhesive protein materials | Aug 27, 2019 | Issued |
Array
(
[id] => 15899105
[patent_doc_number] => 20200149071
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-05-14
[patent_title] => YEAST STRAIN WITH GLUCOSE AND XYLOSE CO-UTILIZATION CAPACITY
[patent_app_type] => utility
[patent_app_number] => 16/551335
[patent_app_country] => US
[patent_app_date] => 2019-08-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7210
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 129
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16551335
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/551335 | Yeast strain with glucose and xylose co-utilization capacity | Aug 25, 2019 | Issued |
Array
(
[id] => 15616085
[patent_doc_number] => 20200078447
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-03-12
[patent_title] => FACTOR VIII FORMULATIONS
[patent_app_type] => utility
[patent_app_number] => 16/547409
[patent_app_country] => US
[patent_app_date] => 2019-08-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15724
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16547409
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/547409 | Factor VIII formulations | Aug 20, 2019 | Issued |
Array
(
[id] => 17008556
[patent_doc_number] => 20210239717
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-08-05
[patent_title] => MICROSAMPLING DETECTION IN DIABETES
[patent_app_type] => utility
[patent_app_number] => 17/269926
[patent_app_country] => US
[patent_app_date] => 2019-08-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5735
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17269926
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/269926 | MICROSAMPLING DETECTION IN DIABETES | Aug 20, 2019 | Abandoned |
Array
(
[id] => 15254137
[patent_doc_number] => 20190375802
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-12-12
[patent_title] => NOVEL NUCLEOSIDE TRIPHOSPHATE TRANSPORTER AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/546097
[patent_app_country] => US
[patent_app_date] => 2019-08-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32210
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -29
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16546097
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/546097 | Nucleoside triphosphate transporter and uses thereof | Aug 19, 2019 | Issued |
Array
(
[id] => 15254139
[patent_doc_number] => 20190375803
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-12-12
[patent_title] => NOVEL NUCLEOSIDE TRIPHOSPHATE TRANSPORTER AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/546100
[patent_app_country] => US
[patent_app_date] => 2019-08-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32199
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 69
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16546100
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/546100 | Nucleoside triphosphate transporter and uses thereof | Aug 19, 2019 | Issued |
Array
(
[id] => 15035679
[patent_doc_number] => 20190328844
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-10-31
[patent_title] => NANOPARTICLES FOR THE THERAPEUTIC TREATMENT OF RADIATION-INDUCED SKIN ULCERS
[patent_app_type] => utility
[patent_app_number] => 16/505257
[patent_app_country] => US
[patent_app_date] => 2019-07-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9138
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 78
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16505257
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/505257 | Nanoparticles for the therapeutic treatment of radiation-induced skin ulcers | Jul 7, 2019 | Issued |
Array
(
[id] => 15294225
[patent_doc_number] => 20190390248
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-12-26
[patent_title] => SERUM PREPARATION
[patent_app_type] => utility
[patent_app_number] => 16/504033
[patent_app_country] => US
[patent_app_date] => 2019-07-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 55713
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16504033
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/504033 | SERUM PREPARATION | Jul 4, 2019 | Abandoned |
Array
(
[id] => 15321271
[patent_doc_number] => 20200000965
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-01-02
[patent_title] => STABILIZATION OF COLLAGEN SCAFFOLDS
[patent_app_type] => utility
[patent_app_number] => 16/460576
[patent_app_country] => US
[patent_app_date] => 2019-07-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14175
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -56
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16460576
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/460576 | STABILIZATION OF COLLAGEN SCAFFOLDS | Jul 1, 2019 | Pending |
Array
(
[id] => 17038246
[patent_doc_number] => 20210255205
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-08-19
[patent_title] => COMPOSITIONS AND METHODS FOR TREATING METABOLIC DISEASE
[patent_app_type] => utility
[patent_app_number] => 17/255827
[patent_app_country] => US
[patent_app_date] => 2019-06-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27838
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17255827
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/255827 | COMPOSITIONS AND METHODS FOR TREATING METABOLIC DISEASE | Jun 26, 2019 | Abandoned |
Array
(
[id] => 15321265
[patent_doc_number] => 20200000962
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-01-02
[patent_title] => LOAD BEARING CROWDED COLLAGEN CONSTRUCTS
[patent_app_type] => utility
[patent_app_number] => 16/453717
[patent_app_country] => US
[patent_app_date] => 2019-06-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7932
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16453717
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/453717 | LOAD BEARING CROWDED COLLAGEN CONSTRUCTS | Jun 25, 2019 | Abandoned |
Array
(
[id] => 15035331
[patent_doc_number] => 20190328670
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-10-31
[patent_title] => Microparticles for Oral Delivery
[patent_app_type] => utility
[patent_app_number] => 16/448539
[patent_app_country] => US
[patent_app_date] => 2019-06-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17171
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16448539
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/448539 | Microparticles for Oral Delivery | Jun 20, 2019 | Abandoned |
Array
(
[id] => 17681178
[patent_doc_number] => 11365419
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-06-21
[patent_title] => Host cell and method for producing target protein using same
[patent_app_type] => utility
[patent_app_number] => 16/441424
[patent_app_country] => US
[patent_app_date] => 2019-06-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16111
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 257
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16441424
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/441424 | Host cell and method for producing target protein using same | Jun 13, 2019 | Issued |
Array
(
[id] => 17037124
[patent_doc_number] => 20210254082
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-08-19
[patent_title] => Promoter for Yeast
[patent_app_type] => utility
[patent_app_number] => 15/734682
[patent_app_country] => US
[patent_app_date] => 2019-06-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7798
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15734682
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/734682 | Promoter for yeast | Jun 2, 2019 | Issued |
Array
(
[id] => 15254637
[patent_doc_number] => 20190376052
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-12-12
[patent_title] => GLUCANASES, NUCLEIC ACIDS ENCODING THEM AND METHODS FOR MAKING AND USING THEM
[patent_app_type] => utility
[patent_app_number] => 16/424391
[patent_app_country] => US
[patent_app_date] => 2019-05-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 118519
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -31
[patent_words_short_claim] => 1998
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16424391
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/424391 | GLUCANASES, NUCLEIC ACIDS ENCODING THEM AND METHODS FOR MAKING AND USING THEM | May 27, 2019 | Abandoned |
Array
(
[id] => 16867683
[patent_doc_number] => 20210161150
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-06-03
[patent_title] => METHODS AND COMPOSITIONS FOR KILLING A TARGET BACTERIUM
[patent_app_type] => utility
[patent_app_number] => 17/057601
[patent_app_country] => US
[patent_app_date] => 2019-05-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29328
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -204
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17057601
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/057601 | METHODS AND COMPOSITIONS FOR KILLING A TARGET BACTERIUM | May 23, 2019 | Abandoned |
Array
(
[id] => 16961562
[patent_doc_number] => 20210213061
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-15
[patent_title] => GENETICALLY ENGINEERED CELL AND APPLICATION THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/055470
[patent_app_country] => US
[patent_app_date] => 2019-05-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17492
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -36
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17055470
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/055470 | Genetically engineered cell and application thereof | May 14, 2019 | Issued |
Array
(
[id] => 14990097
[patent_doc_number] => 20190314006
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-10-17
[patent_title] => DEVICE AND METHOD FOR PREPARING AND ADMINISTERING ONE-COMPONENT FIBRIN SEALANT
[patent_app_type] => utility
[patent_app_number] => 16/412487
[patent_app_country] => US
[patent_app_date] => 2019-05-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17367
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16412487
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/412487 | Device and method for preparing and administering one-component fibrin sealant | May 14, 2019 | Issued |
Array
(
[id] => 14778581
[patent_doc_number] => 20190264188
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-08-29
[patent_title] => RECOMBINANT VITAMIN K DEPENDENT PROTEINS WITH HIGH SIALIC ACID CONTENT AND METHODS OF PREPARING SAME
[patent_app_type] => utility
[patent_app_number] => 16/409385
[patent_app_country] => US
[patent_app_date] => 2019-05-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6531
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16409385
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/409385 | RECOMBINANT VITAMIN K DEPENDENT PROTEINS WITH HIGH SIALIC ACID CONTENT AND METHODS OF PREPARING SAME | May 9, 2019 | Abandoned |
Array
(
[id] => 15681803
[patent_doc_number] => 20200095565
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-03-26
[patent_title] => METHODS AND COMPOSITIONS FOR MODIFIED FACTOR IX PROTEINS
[patent_app_type] => utility
[patent_app_number] => 16/401987
[patent_app_country] => US
[patent_app_date] => 2019-05-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18140
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 79
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16401987
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/401987 | METHODS AND COMPOSITIONS FOR MODIFIED FACTOR IX PROTEINS | May 1, 2019 | Abandoned |